FDA APPROVES MONOCLONAL ANTIBODY FOR ASTHMA

摘要

The US Food and Drug Administration (FDA) has approved mepolizumab (GlaxoSmithKline's Nucala), a humanised interleukin-5 antagonist monoclonal antibody, to treat asthma with other drugs in patients aged 12 years and over.